A Cell Press partner journal
See the unseen. Change the unchanged.
The Innovation ¡ª published by Cell Press in partnership with members of the Youth
Innovation Promotion Association (YIPA),a part of the Chinese Academy of
Sciences¡ªis a new broad-scope, open access journal publishing basic and applied
research that has impact for the benefit of society.
On the cover: Medicine is the practice of the diagnosis, treatment, and prevention of disease. With the advances in medical science, human beings are getting both longer life spans and higher quality of life. From herbs to molecular signatures, humankind is experiencing a transition from traditional medicine to personalized medicine: the right treatment to the right patient at the right time. However, it is not so easy to achieve this goal because the etiology of most diseases and disorders is still unclear. From description to association, numerous researchers are working together to decipher the mechanisms behind disease. To address such challenges, more and more global collaborations are badly needed to include experts from all disciplines: not just doctors, scientists and administration staff, but also engineers, technicians and marketing managers. Not limited to a fish-eye view, we humans should widen our vision and get more deep insights beyond the human community. That is the right way to assure sustainable healthcare for humanity.
  Related comments
Add comment (English only)
Name*:  
E-mail:  
Telephone:  
Code:    
Comments*:
Position: Home > issue > May 10, 2022 Volume 3, Issue 3
Anticancer drug R&D of gastrointestinal cancer in China: Current landscape and challenges
Category:   Editorial   Download:  PDF  Figure  Endnote
Author: Lin Shen

12.jpg

Challenges in gastrointestinal cancer and strategies in anticancer drug discovery


According to the latest report of cancer epidemiology published in 2022, about 1,500,000 new cases of gastrointestinal (GI) cancers were diagnosed in China, with 1,077,000 registered deaths.1 Both the GI cancer incidence and related deaths in China account for about 50% around the world, and the GI cancer burden is still increasing globally.2 Therefore, Chinese researchers have the responsibility to play a leading role in the prevention, diagnosis, and treatment of GI cancer. For advanced GI cancers, despite progress of conventional chemotherapy, target therapy, and even immunotherapy, long-term survival of patients is still relatively low.





Host
ISSN 2666-6758
Publishing partner
Journal links
 
Academic co-partner
SHANGHAI INSTITUTE OF APPLIED PHYSICS, CAS
INSTITUTE OF MICROBIOLOGY, CAS
XI'AN INSTITUTE OF OPTICS AND PRECISION MECHANICS, CAS
 
Collections

Air Pollution
Astronomy
Cancer
Chemistry & Materials
COVID-19
Environment Changes
Geoscience
Life Science & Medicine
Physics
ScienceX / Interdiscipline

 
Stay connected
  the.innovation.journal
  the.innovation.journal
  The Innovation
  TheInnovation´´ÐÂ
  TheInnovation´´ÐÂ
  The_Innovation
  office@the-innovation.org

Official£º@The_InnovationJ
Astronomy£º@TheInnovationA3
Chemistry£º@InnovationChem
Geoscience£º@TheInnovationG2
Informatics£º@Innovation_inf
Life Science£º@InnovationLS
Management£º@TheInnovationM1
Materials£º@TheInnovationM2
Medicine£º@Theinnovation_m
Physics£º@TheInnovationP1
ScienceX£º@TheInnovSciX

  Copyright © 2019-2022 Youth Innovation All Rights Reserved